Risperidone 4 mg Tablet PCD Franchise in Mumbai

Psychiatric Medicine Supplier in Bangalore

Antipsychotic Drug Distributor in Pune

CNS and Mental Health Pharma Franchise in Delhi NCR

Schizophrenia Treatment Tablet Stockist in Ahmedabad
Risperidone 4 mg Export and Manufacturing in Hyderabad

Home/Products /risperidone-bp-4-mg-tablet

Risplom 4 Tablet

Composition : Risperidone (4mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Risplom 4 Tablet contains Risperidone 4mg, an atypical antipsychotic commonly prescribed for the management of schizophrenia, bipolar disorder, irritability associated with autism, and behavioral disturbances. It works by modulating dopamine and serotonin receptors in the brain, helping control hallucinations, aggression, mood swings, and thought disturbances.

This strength is generally recommended for moderate to severe psychiatric disorders or when lower doses are insufficient. Due to its established therapeutic role and long-term usage pattern, this medicine has a consistent prescription rate across hospitals and mental health care facilities.

Belonging to the CNS and psychiatry segment, Risplom 4 Tablet is widely prescribed by psychiatrists and neurologists and carries strong repeat demand due to chronic treatment protocols.

For PCD pharma franchise holders, wholesale distributors, and exporters, Risplom 4 is a highly scalable and profitable product with steady market growth. It is also available for bulk supply, third-party manufacturing, institutional tie-ups, and private-label exports across India.

Read More

About the Product

Risplom 4 Tablet contains Risperidone 4mg, an atypical antipsychotic commonly prescribed for the management of schizophrenia, bipolar disorder, irritability associated with autism, and behavioral disturbances. It works by modulating dopamine and serotonin receptors in the brain, helping control hallucinations, aggression, mood swings, and thought disturbances.

This strength is generally recommended for moderate to severe psychiatric disorders or when lower doses are insufficient. Due to its established therapeutic role and long-term usage pattern, this medicine has a consistent prescription rate across hospitals and mental health care facilities.

Belonging to the CNS and psychiatry segment, Risplom 4 Tablet is widely prescribed by psychiatrists and neurologists and carries strong repeat demand due to chronic treatment protocols.

For PCD pharma franchise holders, wholesale distributors, and exporters, Risplom 4 is a highly scalable and profitable product with steady market growth. It is also available for bulk supply, third-party manufacturing, institutional tie-ups, and private-label exports across India.

Common side effects include drowsiness, dizziness, weight gain, increased appetite, dry mouth, constipation, and sleep disturbances; less commonly patients may experience extrapyramidal symptoms (movement disorders), elevated prolactin levels, metabolic changes (weight/BG/lipids), or orthostatic dizziness — seek medical help for severe symptoms.

Risplom 4 Tablet is indicated for the treatment of schizophrenia, bipolar disorder (acute mania and maintenance), irritability associated with autism spectrum disorder, and behavioural disturbances related to psychosis; it helps reduce aggression, severe anxiety-driven behaviours, hallucinations, and disorganized thought.

Take Risplom 4 Tablet exactly as prescribed and do not stop it abruptly; inform your doctor about heart disease, diabetes, liver or kidney problems, a history of seizures, or pregnancy; avoid alcohol and activities requiring alertness until you know how it affects you; regular monitoring (weight, glucose, lipids, and movement symptoms) may be required.

Store Risplom 4 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation